Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Johnson & Johnson

Johnson & Johnson, with approximately 104,500 employees, is the world's most comprehensive and broadly-based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical and medical devices and diagnostics markets. Johnson & Johnson has more than 197 operating companies in 54 countries around the world, selling products in more than 175 countries.


Contact Details:
One Johnson & Johnson Plaza
New Brunswick
NJ
08933
United States of America
Tel:732 524 0400
Fax:732 524 2549
Email:jobs@prdus.jnj.com
WWW:

www.jnj.com/




Loading...

Recent Publications by Johnson & Johnson:

Cytoskeletal remodeling during myotube assembly and guidance: Coordinating the actin and microtubule networks.
The formation of a multinucleated muscle fiber from individual myoblasts...
13th November, 2009
Department of Pathology and Laboratory Medicine; Robert Wood Johnson Commun Integr Biol. 2009 Sep;2(5):452-7.
The Histamine H(4) Receptor Mediates Inflammation and Pruritus in Th2-Dependent Dermal Inflammation.
The role of histamine H(4) receptor (H(4)R) was investigated in a T-helper...
13th November, 2009
Department of Immunology, Johnson & Johnson Pharmaceutical Research & J Invest Dermatol. 2009 Nov 12.
DOI Direct Link
Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia.
Ventilatory depression is a significant risk associated with the use of...
13th November, 2009
pharmazentrum frankfurt/ZAFES, Institute for Clinical Pharmacology, Clin Pharmacol Ther. 2009 Nov 11.
DOI Direct Link
Pimavanserin, a Serotonin(2A) Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis.
Psychotic symptoms occur in up to 40% of patients with Parkinson's disease...
13th November, 2009
Department of Psychiatry, Vanderbilt University School of Medicine, Neuropsychopharmacology. 2009 Nov 11.
DOI Direct Link
MEG demonstrates a supra-additive response to facial and vocal emotion in the right superior temporal sulcus.
An influential neural model of face perception suggests that the posterior...
13th November, 2009
Department of Psychology, University of York, Heslington YO10 5DD, United Proc Natl Acad Sci U S A. 2009 Nov 11.
DOI Direct Link

View more Johnson & Johnson research publications.

Press Releases on Johnson & Johnson:

BioPortfolio Logo
Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growth 3rd November, 2009 Johnson & Johnson
NEW BRUNSWICK, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced global restructuring initiatives designed to strengthen the company's position as the
/C O R R E C T I O N -- Johnson & Johnson/ 10th July, 2009 Johnson & Johnson
In the news release, Johnson & Johnson Completes Acquisition of Cougar Biotechnology, issued earlier today by Johnson & Johnson over PR Newswire, we are advised by the company that the second
Johnson & Johnson Completes Acquisition of Cougar Biotechnology 10th July, 2009 Johnson & Johnson
NEW BRUNSWICK, N.J., July 10 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Cougar Biotechnology, Inc., a development
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology 3rd July, 2009 Johnson & Johnson
NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced that the initial offering period of its tender offer for all outstanding shares of common
Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology 17th June, 2009 Johnson & Johnson
NEW BRUNSWICK, N.J., June 17 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced the U.S. Federal Trade Commission has granted early termination of the waiting period under the

BioNews Results for Johnson & Johnson:

UPDATE 2-Bristol-Myers to spin off Mead stock
Reuters:  Nov 16 2009 2:12AM Matching: johnson
Bristol-Myers Squibb To Split Off Stake In Mead Johnson Nutrition - Quick Facts
RTTNews.com:  Nov 16 2009 12:39AM Matching: johnson
Mead Johnson to File Registration Statement; Comments on Bristol-Myers Squibb Announcement to Split-off Mead Johnson
Centre Daily Times:  Nov 16 2009 12:22AM Matching: johnson
Mead Johnson to File Registration Statement; Comments on Bristol-Myers Squibb Announcement to Split-off Mead Johnson
PR inside:  Nov 16 2009 12:09AM Matching: johnson
Mead Johnson to File Registration Statement; Comments on Bristol-Myers Squibb Announcement to Split-off Mead Johnson
Stockwatch:  Nov 16 2009 12:02AM Matching: johnson
Promote your company here: BioNewsCast - Press Release Distribution

View more Johnson & Johnson news.

Johnson & Johnson (JNJ) Financial information Links from Barchart

JNJ Quote from from Barchart.com
JNJ Chart from from Barchart.com
JNJ Profile from from Barchart.com
JNJ Opinion from from Barchart.com

View more Johnson & Johnson finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 856 times since April 2007, the link to the organisation's website has been followed 140 times

Recent Search Terms used to find this page: johnson and johnson email contacts | johnson johnson new brunswick nj prdus.jnj | JOHNSON EMAIL CONTACTS | .

Search for more companies in New Brunswick

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Johnson & Johnson

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.